Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
6000 participants
OBSERVATIONAL
2005-05-31
2014-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However, unfortunately, in Korea, results of systematic clinical trials carried out in the Korean population are not available. All the currently available management guidelines have been formulated based on the results of clinical trials carried out in other populations, on patients with perhaps different characteristics compared to ours. There are quite a number of problems in applying these guidelines to our patients.
This study's purpose is to create a basis on which we could establish effective prevention, diagnosis, and therapeutic plan based on specific characteristics of Korean patients with type 2 diabetes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Korean type 2 diabetic patients
No interventions assigned to this group
Koreans at high risk for diabetes
No interventions assigned to this group
Korean gestational diabetic patients
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* random plasma glucose \>200mg/dL + symptoms such as polyuria, polydipsia, unexplained weight loss
* fasting plasma glucose \>126 mg/dL or 75g oral glucose tolerance test (OGTT) 2h plasma glucose \>200 mg/dL (Group 2: High risk for diabetes based on ADA 2004 guidelines)
* IFG: fasting plasma glucose 100-125 mg/dL and 75g OGTT 2h plasma glucose \<140 mg/dL
* IGT: fasting plasma glucose \<100 mg/dL and 75g OGTT 2h plasma glucose 140-199 mg/dL (Group 3: Gestational Diabetes based on ADA 2004 guidelines)
* 50g OGTT 1h plasma glucose \>140 mg/dl
* 100g OGTT fasting plasma glucose \>95 mg/dl, 1h plasma glucose \>180 mg/dl, 2h plasma glucose \>155 mg/dL, 3h plasma glucose \>140 mg/dL
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Korea University Guro Hospital
OTHER
Hanyang University
OTHER
Inha University Hospital
OTHER
Ajou University
OTHER
East West Neo Medical Center
OTHER
Pusan National University Hospital
OTHER
Gachon University Gil Medical Center
OTHER
Cheil General Hospital and Women's Healthcare Center
OTHER
Yeungnam University Hospital
OTHER
Inje University
OTHER
Kangdong Sacred Heart Hospital
OTHER
Ministry of Health & Welfare, Korea
OTHER_GOV
Kyunghee University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kyunghee University Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young-Seol Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Kyunghee University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hanyang University Medical Center
Guri-si, Kyunggi, South Korea
Gachon University Gil Hospital
Incheon, Namdong, South Korea
Yeungnam University Medical Center
Daegu, , South Korea
Inha University Hospital
Incheon, , South Korea
Pusan National University Hospital
Pusan, , South Korea
Cheil General Hospital
Seoul, , South Korea
Kyunghee University Medical Center
Seoul, , South Korea
Kangdong Sacred Heart Hospital Hallym University
Seoul, , South Korea
Inje University Sanggye-Paik Hospital
Seoul, , South Korea
Korea University Guro Hospital
Seoul, , South Korea
Kyung Hee University East West Neo Medical Center
Seoul, , South Korea
Ajou University Medical Center
Suwon, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kim SH, Hong SB, Suh YJ, Choi YJ, Nam M, Lee HW, Park IeB, Chon S, Woo JT, Baik SH, Park Y, Kim DJ, Lee KW, Kim YS; KNDP Study Group. Association between nutrient intake and obesity in type 2 diabetic patients from the Korean National Diabetes Program: a cross-sectional study. J Korean Med Sci. 2012 Oct;27(10):1188-95. doi: 10.3346/jkms.2012.27.10.1188. Epub 2012 Oct 2.
Choi KM, Hwang SY, Hong HC, Yang SJ, Choi HY, Yoo HJ, Lee KW, Nam MS, Park YS, Woo JT, Kim YS, Choi DS, Youn BS, Baik SH. C1q/TNF-related protein-3 (CTRP-3) and pigment epithelium-derived factor (PEDF) concentrations in patients with type 2 diabetes and metabolic syndrome. Diabetes. 2012 Nov;61(11):2932-6. doi: 10.2337/db12-0217. Epub 2012 Jul 26.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KNDP-KMC-0505
Identifier Type: -
Identifier Source: org_study_id